U-Blot® Research Grade Anti-Human CD135/FLT3 (4G8SDIEM)Cat. No. WA1276Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD135/FLT3 (4G8SDIEM)Cat. No. WA1276
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (ZL-1101)Cat. No. WA1275
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (YH-002)Cat. No. WA1274
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (MSB013)Cat. No. WA1273
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (MEDI 6469)Cat. No. WA1272
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (INCAGN1949)Cat. No. WA1271
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (INBRX-106)Cat. No. WA1270
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (HFB301001)Cat. No. WA1269
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (GSK 3174998)Cat. No. WA1268
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (BMS 986178)Cat. No. WA1267
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (BAT6026)Cat. No. WA1266
U-Blot® Research Grade Anti-Human CD134/TNFRSF4/OX40 (3C8)Cat. No. WA1265